Oxford Specialist Handbook: Myeloproliferative Neoplasms
-10%
portes grátis
Oxford Specialist Handbook: Myeloproliferative Neoplasms
Barbui, Tiziano; Mughal, Tariq I.
Oxford University Press
09/2020
352
Mole
Inglês
9780198744214
15 a 20 dias
164
Descrição não disponível.
1: Tariq I. Mughal and Tiziano Barbui: History of the myeloproliferative neoplasms
2: Srinivas K. Tantravahi, Jamshid S. Khorashad, and Michael W.Deininger: Genomic landscape of myeloproliferative neo-plasms
3: Angela G. Fleischman and Richard A. Van Etten: Pathogenesis of myeloproliferative neoplasms
4: Hans Michael Kvasnicka and Jueergen Thiele: Haematopathology of myeloproliferative neoplasms
5: Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Simona Soverini, and Gianantonio Rosti: Prognostic factors of chronic myeloid leukaemia
6: Paola Guglielmelli and Alessandro M. Vannucchi: Molecular risk stratification of Myeloproliferative Neoplasms
7: Tariq I. Mughal: Chronic myeloid leukaemia
8: Tiziano Barbui and Guido Finazzi: Polycythaemia vera
9: Claire Harrison, Yan Beauverd, and Donal McLorran: Myelofibrosis
10: Carlos Besses, Beatriz Bellosillo, and Alberto Alvarez-Larran: Essential thrombocythemia
11: Jason Gotlib: Systemic mastocytosis
12: Eric Padron, David Sallman, Tariq I. Mughal, and Alan F. List: Myelodysplastic syndromes/myeloproliferative neoplasms
13: Andreas Reiter and Nicholas C. P. Cross: Eosinophilia-associated myeloproliferative neoplasms
14: Omar Abdelwahab, Raajit Rampal, Catriona Jamieson, and Tariq I. Mughal: Transformation of myeloproliferative neoplasms to acute leukaemia
15: Daniel Egan and Jerald P. Radich: Monitoring efforts in myeloproliferative neoplasms
16: Alessandro Rambaldi and Nicholas Kroeger: Stem cell transplantation for BCR-ABL1-postive and negative myeloproliferative neoplasms
17: Holly L. Geyer, Deepti Radia, Nicholas Sarlis, and Ruben A. Mesa: Assessment of disease burden in patients with myeloproliferative neoplasms
18: Giovanni Barosi and Gianni Tognoni: Clinical trials in bcr-abl1-negative myeloproliferative neo-plasms
2: Srinivas K. Tantravahi, Jamshid S. Khorashad, and Michael W.Deininger: Genomic landscape of myeloproliferative neo-plasms
3: Angela G. Fleischman and Richard A. Van Etten: Pathogenesis of myeloproliferative neoplasms
4: Hans Michael Kvasnicka and Jueergen Thiele: Haematopathology of myeloproliferative neoplasms
5: Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Simona Soverini, and Gianantonio Rosti: Prognostic factors of chronic myeloid leukaemia
6: Paola Guglielmelli and Alessandro M. Vannucchi: Molecular risk stratification of Myeloproliferative Neoplasms
7: Tariq I. Mughal: Chronic myeloid leukaemia
8: Tiziano Barbui and Guido Finazzi: Polycythaemia vera
9: Claire Harrison, Yan Beauverd, and Donal McLorran: Myelofibrosis
10: Carlos Besses, Beatriz Bellosillo, and Alberto Alvarez-Larran: Essential thrombocythemia
11: Jason Gotlib: Systemic mastocytosis
12: Eric Padron, David Sallman, Tariq I. Mughal, and Alan F. List: Myelodysplastic syndromes/myeloproliferative neoplasms
13: Andreas Reiter and Nicholas C. P. Cross: Eosinophilia-associated myeloproliferative neoplasms
14: Omar Abdelwahab, Raajit Rampal, Catriona Jamieson, and Tariq I. Mughal: Transformation of myeloproliferative neoplasms to acute leukaemia
15: Daniel Egan and Jerald P. Radich: Monitoring efforts in myeloproliferative neoplasms
16: Alessandro Rambaldi and Nicholas Kroeger: Stem cell transplantation for BCR-ABL1-postive and negative myeloproliferative neoplasms
17: Holly L. Geyer, Deepti Radia, Nicholas Sarlis, and Ruben A. Mesa: Assessment of disease burden in patients with myeloproliferative neoplasms
18: Giovanni Barosi and Gianni Tognoni: Clinical trials in bcr-abl1-negative myeloproliferative neo-plasms
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
1: Tariq I. Mughal and Tiziano Barbui: History of the myeloproliferative neoplasms
2: Srinivas K. Tantravahi, Jamshid S. Khorashad, and Michael W.Deininger: Genomic landscape of myeloproliferative neo-plasms
3: Angela G. Fleischman and Richard A. Van Etten: Pathogenesis of myeloproliferative neoplasms
4: Hans Michael Kvasnicka and Jueergen Thiele: Haematopathology of myeloproliferative neoplasms
5: Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Simona Soverini, and Gianantonio Rosti: Prognostic factors of chronic myeloid leukaemia
6: Paola Guglielmelli and Alessandro M. Vannucchi: Molecular risk stratification of Myeloproliferative Neoplasms
7: Tariq I. Mughal: Chronic myeloid leukaemia
8: Tiziano Barbui and Guido Finazzi: Polycythaemia vera
9: Claire Harrison, Yan Beauverd, and Donal McLorran: Myelofibrosis
10: Carlos Besses, Beatriz Bellosillo, and Alberto Alvarez-Larran: Essential thrombocythemia
11: Jason Gotlib: Systemic mastocytosis
12: Eric Padron, David Sallman, Tariq I. Mughal, and Alan F. List: Myelodysplastic syndromes/myeloproliferative neoplasms
13: Andreas Reiter and Nicholas C. P. Cross: Eosinophilia-associated myeloproliferative neoplasms
14: Omar Abdelwahab, Raajit Rampal, Catriona Jamieson, and Tariq I. Mughal: Transformation of myeloproliferative neoplasms to acute leukaemia
15: Daniel Egan and Jerald P. Radich: Monitoring efforts in myeloproliferative neoplasms
16: Alessandro Rambaldi and Nicholas Kroeger: Stem cell transplantation for BCR-ABL1-postive and negative myeloproliferative neoplasms
17: Holly L. Geyer, Deepti Radia, Nicholas Sarlis, and Ruben A. Mesa: Assessment of disease burden in patients with myeloproliferative neoplasms
18: Giovanni Barosi and Gianni Tognoni: Clinical trials in bcr-abl1-negative myeloproliferative neo-plasms
2: Srinivas K. Tantravahi, Jamshid S. Khorashad, and Michael W.Deininger: Genomic landscape of myeloproliferative neo-plasms
3: Angela G. Fleischman and Richard A. Van Etten: Pathogenesis of myeloproliferative neoplasms
4: Hans Michael Kvasnicka and Jueergen Thiele: Haematopathology of myeloproliferative neoplasms
5: Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Simona Soverini, and Gianantonio Rosti: Prognostic factors of chronic myeloid leukaemia
6: Paola Guglielmelli and Alessandro M. Vannucchi: Molecular risk stratification of Myeloproliferative Neoplasms
7: Tariq I. Mughal: Chronic myeloid leukaemia
8: Tiziano Barbui and Guido Finazzi: Polycythaemia vera
9: Claire Harrison, Yan Beauverd, and Donal McLorran: Myelofibrosis
10: Carlos Besses, Beatriz Bellosillo, and Alberto Alvarez-Larran: Essential thrombocythemia
11: Jason Gotlib: Systemic mastocytosis
12: Eric Padron, David Sallman, Tariq I. Mughal, and Alan F. List: Myelodysplastic syndromes/myeloproliferative neoplasms
13: Andreas Reiter and Nicholas C. P. Cross: Eosinophilia-associated myeloproliferative neoplasms
14: Omar Abdelwahab, Raajit Rampal, Catriona Jamieson, and Tariq I. Mughal: Transformation of myeloproliferative neoplasms to acute leukaemia
15: Daniel Egan and Jerald P. Radich: Monitoring efforts in myeloproliferative neoplasms
16: Alessandro Rambaldi and Nicholas Kroeger: Stem cell transplantation for BCR-ABL1-postive and negative myeloproliferative neoplasms
17: Holly L. Geyer, Deepti Radia, Nicholas Sarlis, and Ruben A. Mesa: Assessment of disease burden in patients with myeloproliferative neoplasms
18: Giovanni Barosi and Gianni Tognoni: Clinical trials in bcr-abl1-negative myeloproliferative neo-plasms
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.